These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Anti-viral treatment: pro or cons type I IFN?]. Whitehead P; Drouet B; Zagury D; Bensussan A Med Sci (Paris); 2013 Oct; 29(10):836-9. PubMed ID: 24148119 [No Abstract] [Full Text] [Related]
4. Targeting of type I interferon in systemic autoimmune diseases. Crow MK; Olferiev M; Kirou KA Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480 [TBL] [Abstract][Full Text] [Related]
5. [Plasmacytoid dendritic cells as therapeutic targets in novel therapeutics for autoimmune diseases]. Ito T Rinsho Ketsueki; 2011 Jul; 52(7):521-30. PubMed ID: 21821984 [No Abstract] [Full Text] [Related]
7. The type I interferon system in the development of lupus. Rönnblom L; Alm GV; Eloranta ML Semin Immunol; 2011 Apr; 23(2):113-21. PubMed ID: 21292501 [TBL] [Abstract][Full Text] [Related]
8. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297 [TBL] [Abstract][Full Text] [Related]
9. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Banchereau J; Pascual V Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570 [TBL] [Abstract][Full Text] [Related]
10. Immune response potential and its genetic regulation in autoimmune diseases. Alterations in systemic lupus erythematosus and thyroid autoimmune diseases. Bentwich Z; Shalev Y; Segal R; Katz D; Mozes E Ann N Y Acad Sci; 1986; 475():227-30. PubMed ID: 2947529 [No Abstract] [Full Text] [Related]
11. [Pathological consequences of excess of interferon in vivo]. Lebon P; Crow YJ; Casanova JL; Gresser I Med Sci (Paris); 2019 Mar; 35(3):232-235. PubMed ID: 30931907 [TBL] [Abstract][Full Text] [Related]
13. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. Long H; Yin H; Wang L; Gershwin ME; Lu Q J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525 [TBL] [Abstract][Full Text] [Related]
14. Interferons and immune reactivity. Hooks JJ; Detrick-Hooks B; Levinson AI J Am Vet Med Assoc; 1982 Nov; 181(10):1111-4. PubMed ID: 6184354 [No Abstract] [Full Text] [Related]
15. Type I interferonopathies: a novel set of inborn errors of immunity. Crow YJ Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056 [TBL] [Abstract][Full Text] [Related]
16. Type I interferon. Niewold TB Cytokine; 2020 Aug; 132():155109. PubMed ID: 32336557 [No Abstract] [Full Text] [Related]
17. Type I interferonopathies in pediatric rheumatology. Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006 [TBL] [Abstract][Full Text] [Related]